التفاصيل البيبلوغرافية
العنوان: |
Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer |
المؤلفون: |
Liu, J.F. *, Barry, W.T., Birrer, M., Lee, J.-M., Buckanovich, R.J., Fleming, G.F., Rimel, B.J., Buss, M.K., Nattam, S.R., Hurteau, J., Luo, W., Curtis, J., Whalen, C., Kohn, E.C., Ivy, S.P., Matulonis, U.A. |
المصدر: |
In Annals of Oncology April 2019 30(4):551-557 |
قاعدة البيانات: |
ScienceDirect |